Optimer Pharmaceuticals, Inc. (OPTR)
-NasdaqGS 14.48 
0.19(1.30%) May 24, 4:00PM EDT|After Hours
:
14.48 0.00 (0.02%) May 24, 4:36PM EDT
| Prev Close: | 14.67 |
|---|
| Open: | 14.58 |
|---|
| Bid: | 13.01 x 200 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 17.43 |
|---|
| Beta: | 0.75 |
|---|
| Next Earnings Date: | 31-Jul-13 |
|---|
| Day's Range: | 14.30 - 14.61 |
|---|
| 52wk Range: | 8.64 - 16.80 |
|---|
| Volume: | 422,811 |
|---|
| Avg Vol (3m): | 1,001,630 |
|---|
| Market Cap: | 705.47M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.21 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 2 Biotechs to Avoid, 1 to Buyat Motley Fool(Thu, May 23)
- Cubist, Optimer, Trius: Antibiotic Deal Making On Tapat TheStreet(Wed, May 22)
- OPTIMER PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Fri, May 17)
- Cubist bid for Optimer before sale process began-sourcesat Reuters(Wed, May 15)
- Cubist bid almost $1 billion for Optimer before sale process: sourcesat Reuters(Wed, May 15)
- Cubist bid almost $1 bln for Optimer before sale process-sourcesat Reuters(Wed, May 15)
- Is AstraZeneca Gearing Up for a Shopping Spree?at Motley Fool(Wed, May 15)
- Markman Hearing A Likely Clearing Event For Cubist - Decision Any Dayat Seeking Alpha(Tue, May 14)
- AstraZeneca, Cubist, Astellas Said to Bid for Optimerat Bloomberg(Tue, May 14)
- Optimer gets bids from AstraZeneca, Cubist, Astellas, Bloomberg saystheflyonthewall.com(Mon, May 13)
- Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating OfficerPR Newswire(Mon, May 13)
- 3 Biotech Stocks Spiking With Big Volumeat TheStreet(Mon, May 13)
- OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PrEDGAR Online(Mon, May 13)
- Investors are Digesting These Healthcare Stock Earnings Insightsat Wall St. Cheat Sheet(Sun, May 12)
- The Best- And Worst-Performing Biotech Stocks, May 3 To May 10at Forbes(Sat, May 11)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 6.71 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -2.23 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.61 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | -0.39 |
|---|
Business Summary
Optimer Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and Canada.
View More